Premier Diagnostic Health Services Inc.

Premier Diagnostic Health Services Inc.

August 22, 2011 14:44 ET

PDH Announces $250,000 Private Placement

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 22, 2011) -


Premier Diagnostic Health Service Inc. ("PDH") (CNSX:PDH) today announced an offering to shareholders of the Company, who are accredited investors, for 3,125,000 units at $0.08 per unit for a total investment of $250,000. Each unit consists of one common share of PDH and one purchase warrant to subscribe to a further share of PDH at $0.10 per share. The warrants are non-transferable and will expire on September 30, 2013.

This offering will expire at 2:00 p.m. on September 9, 2011. The Company may carry out periodic closings during the term of the offering.

PDH is conducting this private placement with internal resources only. The authorized representatives of the Company regarding this offering are Leanne Ratzlaff, Investor Relations, Larry Straith, CEO, Iain Snee, COO, and Geoff Waters, Director.

The funds from this offering will be used to implement PDH's Business Plan (dated August 22, 2011) to deliver management, quality, and financial services to hospitals seeking to increase their medical diagnostics capacity and capability, and for general working capital purposes.

More details about the Business Plan, term sheet, subscription form, and authorized representatives are available on the company's website (

Except for historical information contained herein, this news release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by Premier.

About Premier Diagnostic Health Services Inc. ("PDH")

Premier is a Canadian company accelerating international access to advanced medical diagnostic tools and skills. The company's vision is to provide services and partnership opportunities that support "improving medical decisions" around the world. The company's approach involves building long-term relationships covering management, quality, and financial services that are necessary to build, operate, and grow hospitals' diagnostic capacity and capability.

Contact Information